Wang L, Li H, Wang S, Gong J, Zeng X, Li R, Nong Y, Huang Y, Chen X, Huang Z
Department of Epidemiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005.
Zhonghua Yu Fang Yi Xue Za Zhi. 1999 Mar;33(2):104-6.
To compare the cost-benefit of immunization with hepatitis B (HB) vaccine in different endemic areas of HB and to explore the optimal strategy for it.
Cost-benefit analysis and comprehensive weighted score analysis (CWSA) were used to screen the optimal immunization strategy for low, medium and heavy endemic areas of HB.
Significant economic benefit was obtained in Long-An County, Guangxi Zhuang Autonomous Region, Shanghai and Jinan, Shandong Province from HB immunization programs for infants. The greatest benefit cost ratio (BCR) was provided by the low-dose immunization strategy, which was 49.91, 54.53 and 37.68, respectively for heavy, medium and low endemic areas of HB. The maximal net benefit could be obtained by the high-dose immunization strategy with better immune protective efficacy. CWSA showed that the low-dose immunization strategy was the optimal one for HB immunization.
It is suggested that the low-dose immunization strategy be implemented in undeveloped areas to obtain a greater BCR, and the high-dose one be implemented in more developed areas to obtain more net benefit and lower prevalence of hepatitis B surface antigen carriage.
比较不同乙肝(HB)流行地区乙肝疫苗免疫接种的成本效益,探索其最佳策略。
采用成本效益分析和综合加权评分分析(CWSA)筛选HB低、中、高流行地区的最佳免疫策略。
广西壮族自治区隆安县、上海以及山东省济南市通过婴儿乙肝免疫接种项目获得了显著的经济效益。低剂量免疫策略提供了最大的效益成本比(BCR),HB高、中、低流行地区分别为49.91、54.53和37.68。具有更好免疫保护效果的高剂量免疫策略可获得最大净效益。CWSA显示低剂量免疫策略是HB免疫接种的最佳策略。
建议在欠发达地区实施低剂量免疫策略以获得更大的BCR,在较发达地区实施高剂量免疫策略以获得更多净效益并降低乙肝表面抗原携带率。